🩸
Blood Cancers
Our haematological malignancy research covers leukaemias, lymphomas, and myelomas, with a focus on precision medicine and novel CAR-T cell therapies.
Learn More450+
Bone marrow transplants performed
78
CAR-T patients treated
92%
Complete remission rate (ALL)
Research Themes
1
Affordable CAR-T Cell Therapy
Developing in-house CAR-T manufacturing protocols that reduce treatment costs from $400,000 to under $30,000 per patient.
2
Minimal Residual Disease Monitoring
Flow cytometry and next-generation sequencing–based MRD detection to guide treatment de-escalation in acute leukaemias.
3
Lymphoma Genomics
Characterizing the mutational landscape of diffuse large B-cell lymphoma in Indian patients to identify prognostic biomarkers.
Clinical Trials
NCT06234504
RecruitingPhase I/II Indigenous Anti-CD19 CAR-T in Relapsed ALL
PI: Dr. T. Rajkumar
NCT06234505
ActiveIbrutinib + Venetoclax in Treatment-Naive CLL
PI: Dr. R. Swaminathan
Fund Blood Cancer Breakthroughs
Donations support our pioneering CAR-T cell therapy program and help make life-saving treatments accessible to every patient regardless of economic status.
Donate Now